MRKR Annual Operating Profit
-$14.58 M
+$5.21 M+26.32%
31 December 2023
Summary:
As of January 23, 2025, MRKR annual operaing income is -$14.58 million, with the most recent change of +$5.21 million (+26.32%) on December 31, 2023. During the last 3 years, it has risen by +$13.84 million (+48.69%). MRKR annual operating profit is now -3738.22% below its all-time high of -$379.90 thousand, reached on December 31, 2001.MRKR Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRKR Quarterly Operating Profit
-$2.40 M
-$91.80 K-3.98%
30 September 2024
Summary:
As of January 23, 2025, MRKR quarterly operating income is -$2.40 million, with the most recent change of -$91.80 thousand (-3.98%) on September 30, 2024. Over the past year, it has dropped by -$91.80 thousand (-3.98%). MRKR quarterly operating profit is now -449.08% below its all-time high of $687.50 thousand, reached on December 31, 2000.MRKR Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRKR TTM Operating Profit
-$10.19 M
+$800.10 K+7.28%
30 September 2024
Summary:
As of January 23, 2025, MRKR TTM operating income is -$10.19 million, with the most recent change of +$800.10 thousand (+7.28%) on September 30, 2024. Over the past year, it has increased by +$800.10 thousand (+7.28%). MRKR TTM operating profit is now -3035.44% below its all-time high of $347.30 thousand, reached on September 30, 2001.MRKR TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRKR Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +26.3% | -4.0% | +7.3% |
| 3 y3 years | +48.7% | -4.0% | +7.3% |
| 5 y5 years | +90.2% | +59.3% | +56.3% |
MRKR Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +63.1% | -4.0% | +75.5% | at high | +74.8% |
| 5 y | 5-year | at high | +63.1% | -4.0% | +78.0% | at high | +74.8% |
| alltime | all time | -3738.2% | +90.2% | -449.1% | +98.2% | -3035.4% | +93.3% |
Marker Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.40 M(+4.0%) | -$10.19 M(-7.3%) |
| June 2024 | - | -$2.31 M(-9.5%) | -$10.99 M(-14.2%) |
| Mar 2024 | - | -$2.55 M(-13.2%) | -$12.82 M(-12.1%) |
| Dec 2023 | -$14.58 M(-26.3%) | -$2.94 M(-8.2%) | -$14.58 M(-0.7%) |
| Sept 2023 | - | -$3.20 M(-22.6%) | -$14.68 M(-15.2%) |
| June 2023 | - | -$4.13 M(-4.1%) | -$17.31 M(-6.2%) |
| Mar 2023 | - | -$4.31 M(+41.8%) | -$18.44 M(-22.9%) |
| Dec 2022 | -$19.79 M(-49.9%) | -$3.04 M(-47.8%) | -$23.93 M(-21.9%) |
| Sept 2022 | - | -$5.83 M(+10.6%) | -$30.65 M(-12.0%) |
| June 2022 | - | -$5.27 M(-46.2%) | -$34.85 M(-13.9%) |
| Mar 2022 | - | -$9.79 M(+0.3%) | -$40.49 M(+2.6%) |
| Dec 2021 | -$39.48 M(+38.9%) | -$9.76 M(-2.6%) | -$39.48 M(+3.3%) |
| Sept 2021 | - | -$10.02 M(-8.1%) | -$38.22 M(+7.4%) |
| June 2021 | - | -$10.91 M(+24.2%) | -$35.57 M(+16.4%) |
| Mar 2021 | - | -$8.78 M(+3.2%) | -$30.56 M(+7.5%) |
| Dec 2020 | -$28.42 M(+27.4%) | -$8.51 M(+15.4%) | -$28.42 M(+13.4%) |
| Sept 2020 | - | -$7.38 M(+25.2%) | -$25.06 M(+7.4%) |
| June 2020 | - | -$5.89 M(-11.3%) | -$23.34 M(+0.1%) |
| Mar 2020 | - | -$6.64 M(+29.0%) | -$23.32 M(+4.5%) |
| Dec 2019 | -$22.32 M(-84.9%) | -$5.15 M(-8.9%) | -$22.32 M(-85.4%) |
| Sept 2019 | - | -$5.65 M(-3.7%) | -$153.04 M(+0.8%) |
| June 2019 | - | -$5.87 M(+4.2%) | -$151.81 M(+0.9%) |
| Mar 2019 | - | -$5.64 M(-95.9%) | -$150.41 M(+1.6%) |
| Dec 2018 | -$147.97 M(+1209.8%) | -$135.87 M(+2968.2%) | -$147.97 M(+901.5%) |
| Sept 2018 | - | -$4.43 M(-0.9%) | -$14.77 M(+4.4%) |
| June 2018 | - | -$4.47 M(+39.7%) | -$14.15 M(+17.2%) |
| Mar 2018 | - | -$3.20 M(+19.3%) | -$12.08 M(+6.9%) |
| Dec 2017 | -$11.30 M(+36.7%) | -$2.68 M(-29.6%) | -$11.30 M(+10.7%) |
| Sept 2017 | - | -$3.81 M(+59.1%) | -$10.21 M(+11.9%) |
| June 2017 | - | -$2.39 M(-1.0%) | -$9.12 M(+2.2%) |
| Mar 2017 | - | -$2.42 M(+51.9%) | -$8.92 M(+8.0%) |
| Dec 2016 | -$8.26 M(+34.1%) | -$1.59 M(-41.5%) | -$8.26 M(-7.4%) |
| Sept 2016 | - | -$2.72 M(+24.0%) | -$8.92 M(+12.4%) |
| June 2016 | - | -$2.19 M(+25.1%) | -$7.94 M(+15.3%) |
| Mar 2016 | - | -$1.75 M(-22.2%) | -$6.88 M(+11.8%) |
| Dec 2015 | -$6.16 M(+82.7%) | -$2.25 M(+29.7%) | -$6.16 M(+43.3%) |
| Sept 2015 | - | -$1.74 M(+52.7%) | -$4.30 M(+9.0%) |
| June 2015 | - | -$1.14 M(+10.7%) | -$3.94 M(+18.9%) |
| Mar 2015 | - | -$1.03 M(+160.8%) | -$3.32 M(-4.6%) |
| Dec 2014 | -$3.37 M(+26.5%) | -$394.20 K(-71.5%) | -$3.48 M(-19.0%) |
| Sept 2014 | - | -$1.38 M(+170.8%) | -$4.29 M(+34.2%) |
| June 2014 | - | -$510.90 K(-56.9%) | -$3.20 M(+4.1%) |
| Mar 2014 | - | -$1.19 M(-1.9%) | -$3.07 M(+15.3%) |
| Dec 2013 | -$2.66 M(-51.4%) | -$1.21 M(+316.8%) | -$2.66 M(-2.8%) |
| Sept 2013 | - | -$290.30 K(-24.4%) | -$2.74 M(-9.6%) |
| June 2013 | - | -$383.90 K(-50.8%) | -$3.03 M(-46.7%) |
| Mar 2013 | - | -$780.20 K(-39.4%) | -$5.69 M(+3.7%) |
| Dec 2012 | -$5.48 M | -$1.29 M(+121.3%) | -$5.48 M(+17.1%) |
| Sept 2012 | - | -$581.90 K(-80.8%) | -$4.68 M(-4.5%) |
| June 2012 | - | -$3.04 M(+428.3%) | -$4.90 M(+98.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | -$575.10 K(+17.7%) | -$2.47 M(-6.4%) |
| Dec 2011 | -$2.64 M(-37.7%) | -$488.70 K(-39.0%) | -$2.64 M(-12.9%) |
| Sept 2011 | - | -$801.20 K(+32.8%) | -$3.03 M(+0.9%) |
| June 2011 | - | -$603.30 K(-18.9%) | -$3.00 M(-14.5%) |
| Mar 2011 | - | -$743.60 K(-15.4%) | -$3.51 M(-17.0%) |
| Dec 2010 | -$4.23 M(+0.9%) | -$879.10 K(+13.4%) | -$4.23 M(-34.2%) |
| Sept 2010 | - | -$775.30 K(-30.3%) | -$6.43 M(+5.7%) |
| June 2010 | - | -$1.11 M(-24.0%) | -$6.09 M(+13.3%) |
| Mar 2010 | - | -$1.46 M(-52.5%) | -$5.37 M(+28.1%) |
| Dec 2009 | -$4.19 M(+179.5%) | -$3.08 M(+619.5%) | -$4.19 M(+69.1%) |
| Sept 2009 | - | -$428.30 K(+7.9%) | -$2.48 M(-21.0%) |
| June 2009 | - | -$396.90 K(+38.6%) | -$3.14 M(-15.1%) |
| Mar 2009 | - | -$286.40 K(-79.1%) | -$3.69 M(-4.5%) |
| Dec 2008 | -$1.50 M(-40.3%) | -$1.37 M(+26.0%) | -$3.87 M(+14.4%) |
| Sept 2008 | - | -$1.09 M(+13.9%) | -$3.38 M(+20.8%) |
| June 2008 | - | -$953.00 K(+106.1%) | -$2.80 M(+4.0%) |
| Mar 2008 | - | -$462.30 K(-47.5%) | -$2.69 M(+7.1%) |
| Dec 2007 | -$2.51 M(+182.7%) | -$880.70 K(+75.3%) | -$2.51 M(+31.9%) |
| Sept 2007 | - | -$502.40 K(-40.5%) | -$1.90 M(+9.9%) |
| June 2007 | - | -$845.00 K(+198.3%) | -$1.73 M(+65.1%) |
| Mar 2007 | - | -$283.30 K(+3.4%) | -$1.05 M(+18.2%) |
| Dec 2006 | -$888.20 K(+1.8%) | -$273.90 K(-17.1%) | -$888.20 K(+63.1%) |
| Sept 2006 | - | -$330.20 K(+103.6%) | -$544.60 K(+3.4%) |
| June 2006 | - | -$162.20 K(+33.1%) | -$526.80 K(-36.1%) |
| Mar 2006 | - | -$121.90 K(-274.9%) | -$824.30 K(-5.2%) |
| Dec 2005 | -$872.70 K(-66.3%) | $69.70 K(-122.3%) | -$869.90 K(-55.2%) |
| Sept 2005 | - | -$312.40 K(-32.0%) | -$1.94 M(-4.3%) |
| June 2005 | - | -$459.70 K(+174.4%) | -$2.03 M(-2.9%) |
| Mar 2005 | - | -$167.50 K(-83.3%) | -$2.09 M(-19.4%) |
| Dec 2004 | -$2.59 M(-55.2%) | -$1.00 M(+150.5%) | -$2.59 M(-38.6%) |
| Sept 2004 | - | -$399.40 K(-23.4%) | -$4.22 M(-12.3%) |
| June 2004 | - | -$521.30 K(-22.2%) | -$4.81 M(-13.6%) |
| Mar 2004 | - | -$669.70 K(-74.5%) | -$5.57 M(-3.5%) |
| Dec 2003 | -$5.78 M(+152.9%) | -$2.63 M(+164.9%) | -$5.78 M(+34.7%) |
| Sept 2003 | - | -$993.10 K(-22.4%) | -$4.29 M(+11.6%) |
| June 2003 | - | -$1.28 M(+46.4%) | -$3.85 M(+8.1%) |
| Mar 2003 | - | -$874.60 K(-23.5%) | -$3.56 M(+22.0%) |
| Dec 2002 | -$2.28 M(+501.4%) | -$1.14 M(+109.2%) | -$2.92 M(+60.9%) |
| Sept 2002 | - | -$546.60 K(-44.9%) | -$1.81 M(+37.1%) |
| June 2002 | - | -$992.30 K(+326.4%) | -$1.32 M(+288.2%) |
| Mar 2002 | - | -$232.70 K(+487.6%) | -$340.40 K(-10.4%) |
| Dec 2001 | -$379.90 K(-17.5%) | -$39.60 K(-30.2%) | -$379.80 K(-209.4%) |
| Sept 2001 | - | -$56.70 K(+397.4%) | $347.30 K(-687.6%) |
| June 2001 | - | -$11.40 K(-95.8%) | -$59.10 K(-49.1%) |
| Mar 2001 | - | -$272.10 K(-139.6%) | -$116.20 K(-18.6%) |
| Dec 2000 | -$460.50 K(-56.7%) | $687.50 K(-248.5%) | -$142.70 K(-82.8%) |
| Sept 2000 | - | -$463.10 K(+576.1%) | -$830.20 K(+126.2%) |
| June 2000 | - | -$68.50 K(-77.1%) | -$367.10 K(+22.9%) |
| Mar 2000 | - | -$298.60 K | -$298.60 K |
| Dec 1999 | -$1.06 M | - | - |
FAQ
- What is Marker Therapeutics annual operaing income?
- What is the all time high annual operating profit for Marker Therapeutics?
- What is Marker Therapeutics annual operating profit year-on-year change?
- What is Marker Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Marker Therapeutics?
- What is Marker Therapeutics quarterly operating profit year-on-year change?
- What is Marker Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Marker Therapeutics?
- What is Marker Therapeutics TTM operating profit year-on-year change?
What is Marker Therapeutics annual operaing income?
The current annual operating profit of MRKR is -$14.58 M
What is the all time high annual operating profit for Marker Therapeutics?
Marker Therapeutics all-time high annual operaing income is -$379.90 K
What is Marker Therapeutics annual operating profit year-on-year change?
Over the past year, MRKR annual operaing income has changed by +$5.21 M (+26.32%)
What is Marker Therapeutics quarterly operating income?
The current quarterly operating profit of MRKR is -$2.40 M
What is the all time high quarterly operating profit for Marker Therapeutics?
Marker Therapeutics all-time high quarterly operating income is $687.50 K
What is Marker Therapeutics quarterly operating profit year-on-year change?
Over the past year, MRKR quarterly operating income has changed by -$91.80 K (-3.98%)
What is Marker Therapeutics TTM operating income?
The current TTM operating profit of MRKR is -$10.19 M
What is the all time high TTM operating profit for Marker Therapeutics?
Marker Therapeutics all-time high TTM operating income is $347.30 K
What is Marker Therapeutics TTM operating profit year-on-year change?
Over the past year, MRKR TTM operating income has changed by +$800.10 K (+7.28%)